Ralph, a family dog with dementia, became an unlikely research subject in a groundbreaking study on rapamycin, a drug that may slow aging in both animals and humans. Scientists examining Ralph's brain after his death gained new insights into how the medication affects cognitive decline, contributing to a larger investigation into the drug's potential as an anti-aging treatment. The Rowe family's decision to let researchers study their aging pet reflects a growing collaboration between pet owners and scientists seeking to understand aging through canine subjects, whose lifespans compress human timelines into manageable research windows.